Aptabio Therapeutics

압타바이오 · 293780

Health Care Biotechnology · KOSDAQ

Small-cap

Market cap US$109.1M (₩150.6B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$2.7M

▲ +10.0% YoY

Operating profit · FY2025

−US$11.5M

Loss narrowed

Net income · FY2025

−US$11.8M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$234.7K(₩323.9M)	US$2.4M(₩3.4B)	US$2.7M(₩3.7B)
Operating profit	−US$11.9M(−₩16.4B)	−US$13.7M(−₩18.9B)	−US$11.5M(−₩15.8B)
Net income	−US$8.7M(−₩12.1B)	−US$21.3M(−₩29.4B)	−US$11.8M(−₩16.3B)

Revenue

Operating profit

Net income

ROE

-34.6%

Debt/Eq

27.2%

Op. margin

-428.4%

Net margin

-442.0%

Rev. YoY

▲ +10.0%

Interactive price history isn't here yet. Would you use it?